Ubs Group Ag Abb Vie Inc. Call Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $33.9 Million - $41.3 Million	207,100 Added 34.31%	810,800 $160 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $16.3 Million - $19.1 Million	-105,600 Reduced 14.89%	603,700 $104 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $62.5 Million - $71.2 Million	-390,812 Reduced 35.52%	709,300 $129 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $36.6 Million - $41.2 Million	265,712 Added 31.84%	1,100,112 $170 Million
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $18.3 Million - $21.2 Million	137,200 Added 19.68%	834,400 $124 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $9.34 Million - $11.6 Million	70,500 Added 11.25%	697,200 $93.9 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $6.07 Million - $6.99 Million	-42,000 Reduced 6.28%	626,700 $99.9 Million
Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $48.9 Million - $58.6 Million	353,300 Added 112.02%	668,700 $108 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $5.15 Million - $5.91 Million	-38,400 Reduced 10.85%	315,400 $42.3 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $127 Million - $161 Million	-920,400 Reduced 72.23%	353,800 $54.2 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $13.7 Million - $16.9 Million	-103,474 Reduced 7.51%	1,274,200 $207 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $86 Million - $109 Million	800,813 Added 138.82%	1,377,674 $187 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $22.1 Million - $25.1 Million	208,026 Added 56.4%	576,861 $62.2 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $4.98 Million - $5.55 Million	47,313 Added 14.72%	368,835 $41.5 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $4.93 Million - $5.43 Million	-48,178 Reduced 13.03%	321,522 $34.8 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $6.13 Million - $8.28 Million	76,200 Added 25.96%	369,700 $39.6 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $17,182 - $20,166	-200 Reduced 0.07%	293,500 $25.7 Million
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $11.4 Million - $15.3 Million	-156,000 Reduced 34.69%	293,700 $28.8 Million
Q1 2020 May 01, 2020	SELL	$64.5 - $97.79 $11.8 Million - $17.8 Million	-182,322 Reduced 28.85%	449,700 $34.3 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $22.9 Million - $28.6 Million	317,222 Added 100.77%	632,022 $56 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $4.42 Million - $5.32 Million	-70,200 Reduced 18.23%	314,800 $23.8 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $48.6 Million - $62.1 Million	-739,940 Reduced 65.78%	385,000 $28 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $81.5 Million - $95.9 Million	1,056,200 Added 1536.51%	1,124,940 $90.7 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $3.41 Million - $4.21 Million	43,840 Added 176.06%	68,740 $6.34 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $2.48 Million - $3.33 Million	-27,000 Reduced 52.02%	24,900 $2.36 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $3.51 Million - $3.85 Million	39,208 Added 308.92%	51,900 $5.02 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $579,545 - $740,258	8,297 Added 188.78%	12,692 $1.13 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,760 Added 66.79%	4,395 $319,000
Q1 2017 Nov 14, 2017	BUY	N/A	2,635	2,635 $172,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account